Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors.

Prog Neurobiol

Stem Cells Therapies in Neurodegenerative Diseases Lab, Research Center "Principe Felipe", Valencia, Spain; National Stem Cell Bank-Valencia Node, Platform for Proteomics, Genotyping and Cell Lines, PRB3,ISCIII, Research Center "Principe Felipe", Valencia, Spain; Institute of Experimental Medicine, Czech Academy of Sciences, Department of Neuroregeneration, Prague, Czech Republic. Electronic address:

Published: October 2020

AI Article Synopsis

  • Glaucoma is a major cause of blindness in developing countries, characterized by progressive loss of neural cells in the optic nerve and irreversible vision loss, often associated with increased intraocular pressure (IOP).
  • Although treatment has mainly focused on lowering IOP, some glaucoma cases occur without elevated IOP, suggesting that other molecular changes in retinal ganglion cells (RGCs) may also play a role in the disease.
  • The research proposes using human induced pluripotent stem cells (hiPSCs) to better understand the molecular processes behind glaucoma, drawing parallels between glaucoma and general neurodegeneration for potential insights into treatment.

Article Abstract

Glaucoma, one of the most common causes of blindness in developing countries today, involves a progressive loss of neural cells in the optic nerve that leads to progressive, irreversible vision loss. Increased intraocular pressure (IOP) presents as a major risk factor for glaucoma, although there exist cases of glaucoma patients with normal IOP that exhibit damage to retinal ganglion cells (RGCs) and the optic nerve. However, treatment approaches have maintained their focus on modifying IOP due to a lack of other modifiable risks factors. Traditional concepts in glaucoma involve the neuronal environment and external effects as a source of causative factors; however, studies have yet to investigate whether the molecular profile of RGCs in glaucoma patients makes them more vulnerable and/or susceptible to external damage. Our hypothesis states that molecular changes at the whole cell, gene expression, and electrophysiological level of the neurons can contribute to their degeneration. Herein, we briefly describe different types of glaucoma and any similarities to different molecular and cellular features of neurodegeneration. To test our hypothesis, we describe human induced pluripotent stem cells (hiPSCs) as a reliable cellular tool to model neurodegenerative aspects of glaucoma to reveal the multiple pathological molecular mechanisms underlying disease development.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pneurobio.2020.101817DOI Listing

Publication Analysis

Top Keywords

glaucoma
8
optic nerve
8
glaucoma patients
8
glaucoma neurodegenerative
4
neurodegenerative disease
4
disease caused
4
caused intrinsic
4
intrinsic vulnerability
4
vulnerability factors
4
factors glaucoma
4

Similar Publications

Lost in the Angle: The Mystery of the Missing XEN.

Ophthalmol Glaucoma

January 2025

Department of Ophthalmology, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.

View Article and Find Full Text PDF

Purpose: This study was designed to investigate risk factors for the development of cytomegalovirus (CMV) corneal endotheliitis following corneal transplantation.

Methods: We retrospectively analysed 1225 corneal transplants for bullous keratopathy between 2011 and 2021. 31 cases who were administered the treatment of CMV corneal endotheliitis preoperatively were excluded, and 1194 cases were analysed for risk factors for the development of CMV corneal endotheliitis following corneal transplantation.

View Article and Find Full Text PDF

: To report the role of prostaglandin-associated periorbitopathy (PAP) severity on the surgical efficacy of Ahmed Glaucoma Valve (AGV) implantation. : Retrospective observational case series. Participants were the consecutive 102 eyes from 102 Japanese subjects (55 males, 47 females; mean age ± standard deviation, 74.

View Article and Find Full Text PDF

Stem Cell-Based Therapies for Glaucoma Treatment: A Review Bridging the Gap in Veterinary Patients.

Int J Mol Sci

December 2024

Centro de Estudos de Ciência Animal (CECA), Instituto de Ciências, Tecnologias e Agroambiente (ICETA) da Universidade do Porto (UP), Praça Gomes Teixeira, Apartado 55142, 4051-401 Porto, Portugal.

Retinal diseases are characterized by progressive damage to retinal cells, leading to irreversible vision loss. Among these, glaucoma stands out as a multifactorial neurodegenerative disease involving elevated intraocular pressure, retinal ganglion cell apoptosis, and optic nerve damage, ultimately resulting in blindness in both humans and dogs. Stem cell-based therapies have emerged as a promising therapeutic option for such conditions due to their regenerative and neuroprotective potential.

View Article and Find Full Text PDF

Glaucoma treatment involves reducing the intraocular pressure (IOP), which can damage the optic nerve, to a normal range. Aqueous drainage devices may be used for treatment, and a variety of devices have been proposed. However, they have a non-variable and uniform inner diameter, which makes it difficult to accommodate the IOP fluctuations that occur after glaucoma surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!